Form 4: Xylem Inc. CEO Matthew Pine Reports Stock Transactions
SEC Form 4
Xylem Inc. CEO Matthew Pine reports acquisition and disposal of company stock and stock options related to vesting of performance-based stock units and tax liabilities.
Summary
- On March 1, 2024, Matthew Pine, the President and CEO of Xylem Inc., reported several transactions involving Xylem's common stock.
- These transactions include the acquisition of 3,586 shares upon vesting of performance-based stock units related to ROIC, and 2,206 shares upon vesting of performance-based stock units related to Total Shareholder Return, both granted on March 1, 2021.
- Pine also acquired 12,701 restricted stock units that will vest in increments on March 1, 2025, March 1, 2026 and March 1, 2027.
- Additionally, 42,967 non-qualified stock options were awarded, vesting similarly on March 1, 2025, March 1, 2026 and March 1, 2027.
- Shares were withheld to cover tax liabilities associated with the vesting of performance-based stock units (2,281 shares) and restricted stock units (1,456 shares).
- Following these transactions, Pine directly owns 40,523 shares of common stock and 42,967 stock options.
Sentiment
Score: 6
Explanation: The document is a routine disclosure of stock transactions. The vesting of performance-based units is a positive signal, but the tax-related share withholding is neutral. Overall, the sentiment is moderately positive.
Positives
- The vesting of performance-based stock units indicates achievement of performance criteria related to ROIC and Total Shareholder Return.
- The award of restricted stock units and stock options suggests continued alignment of management's interests with those of shareholders.
Negatives
- The withholding of shares to cover tax liabilities reduces the net increase in the executive's holdings.
Risks
- Future vesting of stock units and options is contingent upon continued employment and potentially further performance achievements.
- Tax liabilities associated with vesting equity may fluctuate based on changes in tax laws and the company's stock price.
Future Outlook
The document outlines the vesting schedule for restricted stock units and stock options, indicating future equity compensation events.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies and are often used to align management's interests with those of shareholders.
Comparison to Industry Standards
- Stock option and restricted stock unit grants are standard compensation practices among publicly traded companies, including Xylem's peers in the industrial sector such as Danaher, Roper Technologies, and Advanced Drainage Systems.
- The vesting schedules and performance-based criteria are also typical, designed to incentivize long-term value creation and retention of key executives.
Stakeholder Impact
- The vesting of performance-based stock units may positively impact shareholders by aligning management incentives with company performance.
- Employees may be affected by the overall compensation structure and incentives provided to executives.
Next Steps
- Continued monitoring of executive stock transactions to assess management's alignment with shareholder interests.
- Tracking the vesting of restricted stock units and stock options in future filings.
Key Dates
| Date | Description |
|---|---|
| 2016-02-24 | Date of the Amended and Restated Xylem Omnibus Incentive Plan. |
| 2021-03-01 | Date of grant for performance-based stock units and restricted stock units. |
| 2022-03-01 | Date of grant for restricted stock units. |
| 2023-03-01 | Date of grant for restricted stock units. |
| 2023-11-08 | Date of Power of Attorney document. |
| 2024-03-01 | Date of stock transactions and grant of stock options and restricted stock units. |
| 2024-03-05 | Date of Form 4 filing. |
| 2025-03-01 | First vesting date for restricted stock units and stock options. |
| 2026-03-01 | Second vesting date for restricted stock units and stock options. |
| 2027-03-01 | Third vesting date for restricted stock units and stock options. |
| 2034-03-01 | Expiration date for stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.